Research presented at the European Society of Cardiology’s annual congress indicates that cholesterol-reducing medications may play a role in dementia prevention. The investigation tracked more than 132,000 Danish residents between 2006 and 2021, with participants who initiated statin therapy demonstrating a 10% reduction in dementia risk overall. Those who began treatment earlier in the study period showed a 15% lower relative risk of developing the condition over a 10-year period, while late initiators experienced a 10% reduction. Among all study participants, approximately 2.7% developed dementia during the follow-up period.
The findings, simultaneously published in the Lancet Regional Health Europe journal, suggest that the timing of intervention may influence outcomes. Researchers propose that statins protect cognitive function by reducing low-density lipoprotein cholesterol, which can harden or narrow blood vessels supplying the brain. By preventing atherosclerosis and maintaining adequate blood flow to brain tissue, these medications may offer protection against cerebrovascular complications associated with cognitive decline.
All study participants had type 2 diabetes, though researchers suggest the results could have broader implications. Dr. Tummas Ternhamar from Copenhagen University Hospital, who presented the research, noted that the findings support addressing dementia risk through multiple interventions simultaneously, with cholesterol management representing one component alongside physical activity and healthy eating. The results align with previous recommendations from the Lancet dementia commission, which identified 14 modifiable risk factors that could prevent or delay approximately 45% of dementia cases.
Experts emphasized that while the study demonstrates an association between statin use and reduced dementia risk, additional research is needed to establish direct causation. Prof Bryan Williams of the British Heart Foundation noted the observational nature of the investigation limits definitive conclusions, though existing trial evidence supports the plausibility of the findings. The widespread availability and affordability of statins suggest potential public health significance if the protective effects are confirmed through further investigation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI